Advances in neural organoids: structural organization, disease modeling, and applications in gene therapy.
Lab-grown brain tissue models enable testing of therapies for rare neurological diseases, reducing reliance on animal studies.
This review outlines the state of neural organoid technology for rare neurological disease modeling and its application as a gene therapy testing platform, covering conditions including spinal muscular atrophy, Rett syndrome, and tuberous sclerosis. Neural organoids represent a significant advance over cell lines for rare disease drug discovery, bridging the gap between simple in vitro models and costly animal studies.
What the study was
- Study design
- Review
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Mol Biol Rep
Why it surfaced
Neural organoids are an emerging platform for rare CNS disease research; gene therapy applications are a watchlist focus; relevant to rare disease monitoring.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.